{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T03:43:16Z","timestamp":1772163796608,"version":"3.50.1"},"reference-count":43,"publisher":"BMJ","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart"],"accepted":{"date-parts":[[2012,7,17]]},"published-print":{"date-parts":[[2013,5,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Most guidelines for treatment of hypertension including the Joint National Committee-7 recommend a blood pressure (BP) goal of &lt;140\/90\u2005mm\u2002Hg for hypertensive patients and a more aggressive goal of &lt;130\/80\u2005mm\u2002Hg for patients with coronary artery disease (CAD), based largely on expert consensus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the BP targets in patients with CAD<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Sources<\/jats:title>\n                    <jats:p>PUBMED, EMBASE and CENTRAL Study Selection: Randomised clinical trials (RCTs) of antihypertensive therapy in patients with CAD, enrolling at least 100 patients, with achieved systolic pressure of &lt;=135 mm Hg in the \u2018intensive BP\u2019 group and &lt;=140 mm Hg in the \u2018standard BP\u2019 group with follow-up for at least 1 year and evaluating cardiovascular outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Extraction<\/jats:title>\n                    <jats:p>The following efficacy outcomes were extracted- all-cause mortality, cardiovascular mortality, myocardial infarction, stroke, angina pectoris, heart failure and revascularisation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 15 RCTs enrolling 66\u2008504 participants with 276\u2008328 patient-years of follow-up. Intensive BP group (\u2264135\u2005mm\u2002Hg) was associated with a 15% decrease in heart failure rate and 10% decrease in stroke rate, driven largely by trials with a more intensive BP group (\u2264130\u2005mm\u2002Hg), with similar outcomes for death and cardiovascular death and was associated with a 105% increase in the risk of hypotension. More intensive BP group (\u2264130\u2005mm\u2002Hg) was also associated with a reduction in myocardial infarction and angina pectoris. The results were similar in a Bayesian random effects model. In addition, lower seemed to be better (based on regression analysis) for the outcomes of myocardial infarction, stroke, heart failure and perhaps angina.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The present body of evidence suggests that in patients with CAD, intensive systolic BP control to \u2264135\u2005mm\u2002Hg and possibly to \u2264130\u2005mm\u2002Hg is associated with a modest reduction in stroke and heart failure but at the expense of hypotension. Lower was better, although not consistently so for myocardial infarction, stroke, heart failure and perhaps angina. Further trials are needed to prove these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/heartjnl-2012-301968","type":"journal-article","created":{"date-parts":[[2012,8,21]],"date-time":"2012-08-21T21:58:14Z","timestamp":1345586294000},"page":"601-613","source":"Crossref","is-referenced-by-count":51,"title":["Blood pressure targets in patients with coronary artery disease: observations from traditional and Bayesian random effects meta-analysis of randomised trials"],"prefix":"10.1136","volume":"99","author":[{"given":"Sripal","family":"Bangalore","sequence":"first","affiliation":[{"name":"Division of Cardiology, New York University School of Medicine, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Kumar","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Nebraska Medical Centre, Omaha, Nebraska, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Volodarskiy","sequence":"additional","affiliation":[{"name":"Division of Cardiology, New York University School of Medicine, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz H","family":"Messerli","sequence":"additional","affiliation":[{"name":"Division of Cardiology, St. Luke's Roosevelt Hospital, Columbia University College of Physicians & Surgeons, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2012,8,21]]},"reference":[{"key":"2025101711514085000_99.9.601.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.19.2560"},{"key":"2025101711514085000_99.9.601.2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm236"},{"key":"2025101711514085000_99.9.601.3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.328.7440.634"},{"key":"2025101711514085000_99.9.601.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001286"},{"key":"2025101711514085000_99.9.601.5","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq328"},{"key":"2025101711514085000_99.9.601.6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.905687"},{"key":"2025101711514085000_99.9.601.7","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-12-200606200-00005"},{"key":"2025101711514085000_99.9.601.8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.016337"},{"key":"2025101711514085000_99.9.601.9","doi-asserted-by":"crossref","unstructured":"Higgins JP Green S . Assessing risk of bias in included studies. Cochrane handbook for systematic reviews of interventions version 500 edn. Oxford: The Cochrane Collaboration, 2008.","DOI":"10.1002\/9780470712184"},{"key":"2025101711514085000_99.9.601.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2009.06.006"},{"key":"2025101711514085000_99.9.601.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)04149-5"},{"key":"2025101711514085000_99.9.601.12","first-page":"86","article-title":"Sbe24: metan\u2014an alternative meta-analysis command","volume":"8","author":"Bradburn","year":"1998","journal-title":"Stata Tech Bull Reprints"},{"key":"2025101711514085000_99.9.601.13","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780070807"},{"key":"2025101711514085000_99.9.601.14","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"2025101711514085000_99.9.601.15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629"},{"key":"2025101711514085000_99.9.601.16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7382.219"},{"key":"2025101711514085000_99.9.601.17","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1752"},{"key":"2025101711514085000_99.9.601.18","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1189"},{"key":"2025101711514085000_99.9.601.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200001203420301"},{"key":"2025101711514085000_99.9.601.20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61242-8"},{"key":"2025101711514085000_99.9.601.21","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.181"},{"key":"2025101711514085000_99.9.601.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16980-8"},{"key":"2025101711514085000_99.9.601.23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.18.2217"},{"key":"2025101711514085000_99.9.601.24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070829"},{"key":"2025101711514085000_99.9.601.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.09.012"},{"key":"2025101711514085000_99.9.601.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14286-9"},{"key":"2025101711514085000_99.9.601.27","doi-asserted-by":"publisher","DOI":"10.1053\/hj.1998.v136.89745"},{"key":"2025101711514085000_99.9.601.28","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp101"},{"key":"2025101711514085000_99.9.601.29","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.685073"},{"key":"2025101711514085000_99.9.601.30","doi-asserted-by":"crossref","first-page":"E20","DOI":"10.1016\/S0002-8703(03)00443-5","article-title":"Effects of low-dose angiotensin II receptor blocker candesartan on cardiovascular events in patients with coronary artery disease","volume":"146","author":"Kondo","year":"2003","journal-title":"Am Heart J"},{"key":"2025101711514085000_99.9.601.31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0801317"},{"key":"2025101711514085000_99.9.601.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)00736-1"},{"key":"2025101711514085000_99.9.601.33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042739"},{"key":"2025101711514085000_99.9.601.34","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.13.1503"},{"key":"2025101711514085000_99.9.601.35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007994"},{"key":"2025101711514085000_99.9.601.36","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.15.1748"},{"key":"2025101711514085000_99.9.601.37","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11911-8"},{"key":"2025101711514085000_99.9.601.38","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(87)90231-5","article-title":"Benefits and potential harm of lowering high blood pressure","volume":"1","author":"Cruickshank","year":"1987","journal-title":"Lancet"},{"key":"2025101711514085000_99.9.601.39","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.303.6799.385"},{"key":"2025101711514085000_99.9.601.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.02.013"},{"key":"2025101711514085000_99.9.601.41","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32832d7370"},{"key":"2025101711514085000_99.9.601.42","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)05381-6"},{"key":"2025101711514085000_99.9.601.43","doi-asserted-by":"publisher","DOI":"10.3109\/08037059209077502"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2012-301968","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T18:51:49Z","timestamp":1760727109000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2012-301968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,21]]},"references-count":43,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,4,5]]},"published-print":{"date-parts":[[2013,5,1]]}},"alternative-id":["10.1136\/heartjnl-2012-301968"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2012-301968","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718004983.793487674","asserted-by":"object"}]},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,21]]}}}